Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0393 | ||||
| Gene Name | SLC52A1 | ||||
| Protein Name | Riboflavin transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | GPCR42; GPR172B; PAR2; PERV-A receptor 2; Porcine endogenous retrovirus A receptor 2; Protein GPR172B; RBFVD; RFT1; RFVT1; SLC52A1; Solute carrier family 52, riboflavin transporter, member 1; hRFT1 | ||||
| DT Family | Eukaryotic Riboflavin Transporter (E-RFT) Family ; | ||||
| Tissue Specificity | Widely expressed. Highly expressed in thetestis, placenta and small intestine. Expressed at lower level inother tissues. | ||||
| Function | This Na(+)-independent transporter mediates the transport of riboflavin. Activity is strongly inhibited by riboflavin analogs, such as lumiflavin. Weakly inhibited by flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN). | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Riboflavin
|
Approved | Drug Info | Acne vulgaris | ED80 | [1] |
| References | |||||
| 1 | An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Mol Genet Metab. 2017 Dec;122(4):182-188. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.